Ocumension Therapeutics (HK:1477) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Ocumension Therapeutics has announced a board meeting scheduled for August 12, 2024, where they will review and approve the interim results for the first half of the year, and discuss the potential issuance of an interim dividend. The meeting will be a significant event for stakeholders as it could influence the company’s stock performance based on the financial outcomes and dividend decisions.
For further insights into HK:1477 stock, check out TipRanks’ Stock Analysis page.